Literature DB >> 11130011

Production and radiochemical separation of the Auger electron emitter 140Nd.

F Rösch1, J Brockmann, N A Lebedev, S M Qaim.   

Abstract

Among the Auger electron emitters, the radiolanthanide 140Nd has some unique nuclear properties with potential for endoradiotherapeutic applications. In the present study, 140Nd was produced via the 140Ce(3He,3n) nuclear process at the FZ Jülich CV28 cyclotron, irradiating CeO2 with 3He particles of 36 MeV primary energy. Yields of about 5 MBq 140Nd per microAh were experimentally obtained. Batch yields of > 100 MBq 140Nd were reached. 140Nd was separated in 75 +/- 5% radiochemical yield using a two-step process, first by extracting the bulk of the target material according to a Ce(IV)/Nd(III) separation, then by final ion exchange purification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130011     DOI: 10.1080/028418600750063794

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  The influence of Bz-DOTA and CHX-A''-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for (114m)In-mediated targeting therapy.

Authors:  Vladimir Tolmachev; Helena Wållberg; Karl Andersson; Anders Wennborg; Hans Lundqvist; Anna Orlova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-09       Impact factor: 9.236

Review 2.  In Vivo Radionuclide Generators for Diagnostics and Therapy.

Authors:  Patricia E Edem; Jesper Fonslet; Andreas Kjær; Matthias Herth; Gregory Severin
Journal:  Bioinorg Chem Appl       Date:  2016-12-12       Impact factor: 7.778

3.  Neodymium-140 DOTA-LM3: Evaluation of an In Vivo Generator for PET with a Non-Internalizing Vector.

Authors:  Gregory W Severin; Lotte K Kristensen; Carsten H Nielsen; Jesper Fonslet; Andreas I Jensen; Anders F Frellsen; K M Jensen; Dennis R Elema; Helmut Maecke; Andreas Kjær; Karl Johnston; Ulli Köster
Journal:  Front Med (Lausanne)       Date:  2017-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.